Resources>Blog>Recombinant Antibodies

Recombinant Antibodies

Biointron 2024-01-20 Read time: 2 mins
Recombinant-antibody.jpg
Image credit: DOI: 10.3389/fvets.2018.00175

Recombinant antibodies are synthetic proteins created by combining different parts of antibody molecules from different sources. These molecules can be customized to target specific antigens, making them a powerful tool in the fields of medicine and biotechnology.

Traditional antibodies are made by the body's immune system to identify and neutralize foreign substances like bacteria or viruses. Recombinant antibodies, on the other hand, are designed in a laboratory to target specific molecules, such as those found on the surface of cancer cells.

One of the main advantages of recombinant antibodies is their ability to be produced on a large scale, making them useful in the development of diagnostic tools and therapeutic drugs. By leveraging mammalian recombinant protein expression, these antibodies can be produced with proper folding and post-translational modifications, ensuring their functionality for therapeutic and research applications.  At Biointron, we specialize in creating high-quality recombinant antibodies through our fast and efficient platform. Our recombinant protein expression service supports the production of these antibodies with precision and scalability, ensuring optimal quality and efficiency. Our team of experts can create recombinant antibodies from scratch, starting with gene synthesis all the way to protein purification. This service is designed to accelerate your research and drug discovery projects with high-quality recombinant antibodies at an economical price.

Our team of experts can create recombinant antibodies from scratch, starting with gene synthesis all the way to protein purification. Our service is designed to accelerate your research and drug discovery projects with high-quality recombinant antibodies at an economical price.

To learn more about how our recombinant antibody service can benefit your research, visit our website at https://www.biointron.com/recombinant-protein-expression/recombinant-protein-expression-in-mammalian-cells.html

Recommended Articles
Biointron Announces RushData Launch Promotion for High-Throughput Antibody Characterization

Biointron announces limited-time RushData launch pricing for high-throughput ant……

Sep 03, 2026
Roundup of Antibody Biotech Deals in August 2026

August 2026 brought another mix of acquisitions, licensing agreements, strategic……

Sep 01, 2026
Understanding Single-Cell Droplet Technology in High-Throughput Antibody Screening

Antibody discovery often begins with a highly diverse population of B cells, onl……

Aug 31, 2026
Beyond Fast Expression: Scaling Antibody Validation to Thousands of Candidates

As larger candidate panels move from computational design into the laboratory, a……

Aug 28, 2026

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.